Ensysce Biosciences, Inc. Gains 32.91%
Wed, Mar 18, 2026 at 07:30 PM
Ensysce Biosciences, Inc. (ENSC:NASDAQ) jumped higher at $0.63, representing a gain of 32.9%. On Wed, Mar 18, 2026, ENSC:NASDAQ touched a New 2-Week High of $0.63. The stock got featured on our News Catalysts scanner on Wed, Mar 04, 2026 at 11:17 AM in the 'MISCELLANEOUS' category. From Wed, Mar 04, 2026, the stock recorded 50.00% Up Days and 45.45% Green Days
The stock spiked on Fri, Feb 27, 2026 at $0.77 with a volume of 282M+.
About Ensysce Biosciences, Inc. (ENSC:NASDAQ)
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs.
Top 10 Gainers:
- Swarmer Inc (SWMR:NASDAQ), 77.42%
- AIM ImmunoTech Inc. (AIM:NYSEMKT), 43.66%
- Twin Vee Powercats Co. (VEEE:NASDAQ), 34.64%
- Ensysce Biosciences, Inc. (ENSC:NASDAQ), 32.91%
- Creative Global Technology Holdings Limited (CGTL:NASDAQ), 30.42%
- Perfect Corp. (PERF:NYSE), 29.63%
- Envirotech Vehicles, Inc. (EVTV:NASDAQ), 27.27%
- Zhengye Biotechnology Holding Limited (ZYBT:NASDAQ), 25.79%
- Tilly's, Inc. (TLYS:NYSE), 23.53%
- Mobile-health Network Solutions (MNDR:NASDAQ), 22.07%